Nida

Nida funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.

2026 NIDA $100,000 Start an SUD Startup Challenge: Six-Month Mentorship and Startup Prizes

The NIDA challenge supports teams turning research ideas in drug use, misuse, or substance use disorder into potential U.S.-based startups through six-month mentorship and up to $100,000 in total cash prizes.

Status: Open Type: Challenge Amount: Up to $100,000 total cash prizes Deadline: Nov 2, 2026 Location: United States and Online

NIH RFA-DA-25-024: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

NIH NIDA RFA-DA-25-024 supports high-priority research at the intersection of HIV and substance use, including prevention, treatment, cure, and implementation work with R01 funding flexibility and clinical trials optional.

Status: Open Type: Grant Amount: $3.0M total FY2025-FY2027; 3–5 awards Deadline: Mar 6, 2027 Location: United States and Global (non-U.S. entities eligible)

NIH RFA-DA-25-060: High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

NIH NIDA RM1 funding for interdisciplinary teams studying HIV and substance use, prioritizing ambitious team-based proposals with a single transformative goal and up to five years of support.

Status: Open Type: Grant Amount: $3.0M total FY2025–FY2027; up to $1.5M direct costs per award year Deadline: Mar 5, 2027 Location: United States

RFA-DA-26-034: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on the Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic Opioids

NIH Trans-NIH RFA supports basic and applied research on acute exposure effects and delayed effects of ultra-potent synthetic opioids, with recurring R01 due dates in 2026 and 2027.

Status: Open Type: Grant Amount: NIH intends up to 4 awards and $2M total in FY 2026 Deadline: Nov 18, 2026 Location: United States and U.S. territories and possessions

RFA-DA-26-055: Accelerating the Pace of Substance Use Research Using Existing Data (R01)

NIH’s NIDA RFA-DA-26-055 supports R01 projects that use existing social, behavioral, administrative, and neuroimaging datasets to advance prevention, treatment, and service-delivery research on substance use, HIV, and related outcomes, without collecting primary data.

Status: Open Type: Grant Amount: NIDA intends to commit $2 million in FY2026 for 2-4 applications, plus an additional $2 million … Deadline: Dec 3, 2026 Location: United States and Global

RFA-DA-26-056: Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

NIDA's RFA-DA-26-056 funds R21 projects that use existing social, behavioral, administrative, and neuroimaging data to study substance use, related disorders, prevention, HIV, and service use without new data collection.

Status: Open Type: Grant Amount: $275,000 maximum in direct costs over two years; no more than $200,000 in any single year Deadline: Dec 3, 2026 Location: United States and International